TECHNOLOGY CORE 2 (TC2) - CRYO-ELECTRON MICROSCOPY (CHENG. CORE LEADER) A.
SPECIFIC AIMS For large complexes, it is essential to bridge the size scales from the atomic-resolution structures of individual subunits to the organization of supramolecular assemblies. EM is ideally suited for this purpose, and every HARC Center project has a single particle cryo-EM component to examine the structures of several HIV/host protein complexes. Consequently, TC2 is designed to enable a broad attack on HIV regulatory complexes by EM. The success of this approach depends on the capacity to align and average a large number of images from molecules with identical structures. We will deal with two key technical issues: that the size of the complexes must be large enough to computationally align images taken from samples embedded in vitreous ice;and that the structural.heterogeneity inherent to many macromolecular assemblies must be adequately dealt with. We will advance the current limitations of cryo- EM to enable studies of small HIV/host complexes with expected structural heterogeneities. We will combine approaches based on cryo-electron tomography (cryo-ET) with those developed for conventional single particle analysis.
In Aim 1, we will establish key experimental methods by studying the trimeric HIV envelope glycoprotein gp120/gp41 and its complex with the host receptor CD4 by conventional single particle methods.
In Aim 2, we will use cryo-ET to study the trimeric gp120/gp41/CD4 complex.
In Aim 3, we will apply the methods developed to other HIV/host protein-nucleic acid complexes, including IN/DNA, Tat-TAR-P-TEFb/RNAP II/DNA, and Rev/RRE/Crm1 complexes. An overall aim of TC2 is to develop new methods that will bridge the gap between macromolecular assemblies that can be determined by cryo-ET and cryo-EM.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center (P50)
Project #
5P50GM082250-04
Application #
8119497
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
4
Fiscal Year
2010
Total Cost
$394,316
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Faust, Tyler B; Li, Yang; Bacon, Curtis W et al. (2018) The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation. Elife 7:
Eckhardt, Manon; Zhang, Wei; Gross, Andrew M et al. (2018) Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein Network. Cancer Discov 8:1474-1489
Masand, Ruchi; Paulo, Esther; Wu, Dongmei et al. (2018) Proteome Imbalance of Mitochondrial Electron Transport Chain in Brown Adipocytes Leads to Metabolic Benefits. Cell Metab 27:616-629.e4
Binning, Jennifer M; Smith, Amber M; Hultquist, Judd F et al. (2018) Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. PLoS Pathog 14:e1006830
Morris, Kyle L; Buffalo, Cosmo Z; Stürzel, Christina M et al. (2018) HIV-1 Nefs Are Cargo-Sensitive AP-1 Trimerization Switches in Tetherin Downregulation. Cell 174:659-671.e14
Chen, Si-Han; Jang, Gwendolyn M; Hüttenhain, Ruth et al. (2018) CRL4AMBRA1 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. EMBO J 37:
Leoz, Marie; Kukanja, Petra; Luo, Zeping et al. (2018) HEXIM1-Tat chimera inhibits HIV-1 replication. PLoS Pathog 14:e1007402
Cheng, Yifan (2018) Single-particle cryo-EM-How did it get here and where will it go. Science 361:876-880
Roth, Theodore L; Puig-Saus, Cristina; Yu, Ruby et al. (2018) Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559:405-409
Ferdin, Jana; Gori?ar, Katja; Dolžan, Vita et al. (2018) Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA. PLoS One 13:e0191613

Showing the most recent 10 out of 199 publications